Molina Healthcare (MOH) Price to Sales (2010 - 2026)

Molina Healthcare has disclosed Price to Sales across 17 years of filings, most recently posting 1.09 for Q2 2026.

• In Q2 2026, Price to Sales fell 22.31% year-over-year to 1.09; the TTM figure through Jun 2026 stood at 0.27 (down 27.91% YoY), while the FY2025 annual figure was 0.19, down 51.41% from the prior year.
• Price to Sales came in at 1.09 for Q2 2026 at Molina Healthcare, up from 0.64 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 2.53 in Q1 2022 to a low of 0.64 in Q1 2026.
• Average Price to Sales over 5 years is 1.58, with a median of 1.6 recorded in 2025.
• Year-over-year, Price to Sales plunged 63.96% in 2022 and surged 176.21% in 2023.
• Over 5 years, Price to Sales stood at 0.81 in 2022, then soared by 187.55% to 2.32 in 2023, then slumped by 32.97% to 1.55 in 2024, then slumped by 49.88% to 0.78 in 2025, then surged by 40.56% to 1.09 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 1.09 in Q2 2026, 0.64 in Q1 2026, and 0.78 in Q4 2025.